Alison Meagher
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
- Pharmacology 15
- Antibiotics Pharmacokinetics and Efficacy 15
-
- Antibiotic Resistance in Bacteria 11
- Co-authors
- Jerome J. Schentag (8 shared papers)Craig R. Rayner (5 shared papers)Mary C. Birmingham (5 shared papers)Alan Forrest (5 shared papers)Evelyn J. Ellis‐Grosse (7 shared papers)Paul G. Ambrose (6 shared papers)Thaddeus H. Grasela (3 shared papers)Donald H. Batts (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (5 papers)Diagnostic Microbiology and Infectious Disease (4 papers)Clinical Infectious Diseases (2 papers)Annals of Pharmacotherapy (2 papers)Clinical Lung Cancer (1 paper)
- Partner nations
- United StatesAustraliaGermany
In The Last Decade
Alison Meagher
23 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 88
- Molecular Medicine 709
- Applied Microbiology and Biotechnology 184
- Clinical Biochemistry 471
- Pharmacology 1.0k
- Infectious Diseases 799
Countries citing papers authored by Alison Meagher
This map shows the geographic impact of Alison Meagher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Meagher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Meagher more than expected).
Fields of papers citing papers by Alison Meagher
This network shows the impact of papers produced by Alison Meagher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Meagher. The network helps show where Alison Meagher may publish in the future.
Co-authors
The 25 scholars most cited alongside Alison Meagher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 324 | |
| 2 | 2003 | 244 | |
| 3 | 2005 | 155 | |
| 4 | 2003 | 129 | |
| 5 | 2005 | 102 | |
| 6 | 2004 | 97 | |
| 7 | 2007 | 90 | |
| 8 | 2007 | 84 | |
| 9 | 2003 | 69 | |
| 10 | 2004 | 62 | |
| 11 | 2006 | 61 | |
| 12 | 2003 | 56 | |
| 13 | 2003 | 53 | |
| 14 | 2002 | 29 | |
| 15 | 2007 | 26 | |
| 16 | 2009 | 17 | |
| 17 | 2008 | 13 | |
| 18 | 2009 | 12 | |
| 19 | 2018 | 5 | |
| 20 | 2012 | 3 |
About Alison Meagher
Alison Meagher is a scholar working on Pharmacology, Molecular Medicine, Infectious Diseases, Clinical Biochemistry and Molecular Biology, having authored 23 papers that have together received 1.6k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (15 papers), Antibiotic Resistance in Bacteria (11 papers), Antimicrobial Resistance in Staphylococcus (7 papers), Bacterial Identification and Susceptibility Testing (6 papers), Pneumonia and Respiratory Infections (3 papers), Cancer therapeutics and mechanisms (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Pharmacological Effects and Toxicity Studies (1 paper). The work is most often cited by research in Molecular Medicine (709 citations), Applied Microbiology and Biotechnology (184 citations), Clinical Biochemistry (471 citations), Pharmacology (1.0k citations) and Infectious Diseases (799 citations). Alison Meagher has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Jerome J. Schentag, Craig R. Rayner, Mary C. Birmingham, Alan Forrest, Evelyn J. Ellis‐Grosse, Paul G. Ambrose, Thaddeus H. Grasela, Donald H. Batts, Scott A. Van Wart and Brenda Cirincione. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Diagnostic Microbiology and Infectious Disease, Clinical Infectious Diseases, Annals of Pharmacotherapy and Clinical Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.